Dare Bioscience (DARE) Misses Q3 EPS by 55c

Dare Bioscience (NASDAQ: DARE) reported Q3 EPS of ($0.55). Revenue for the quarter came in at $41.69 million.

For earnings history and earnings-related data on Dare Bioscience (DARE) click here.

You May Also Be Interested In

• Benchmark Reiterates Buy Rating on Kyivstar Group (KYIV)
• Booking Holdings (BKNG) call put ratio 1 call to 3.4 puts into quarter results
• Blackstone reportedly mulls second debt package for Anthropic chip deal